MRP ₹286
(Inclusive of all Taxes)
₹42.9 Cashback (15%)
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Composition :
ENALAPRILAT-1.25MG
Manufacturer/Marketer :
Cadila Pharmaceuticals Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Have a query?
Drug-Drug Interactions
Severe
Drug-Drug Interactions
Login/Sign Up
How does the drug interact with Envas Injection 1 ml:
Using aliskiren together with Envas Injection 1 ml may increase the risk of serious side effects such as kidney problems, low blood pressure, and high potassium levels in the blood.
How to manage the interaction:
Taking Envas Injection 1 ml with aliskiren is not recommended, but it can be taken together if your doctor advises. However, contact your doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, or feelings of heaviness in the legs. Do not stop taking any medications without consulting a doctor.
Using aliskiren together with Envas Injection 1 ml may increase the risk of serious side effects such as kidney problems, low blood pressure, and high potassium levels in the blood.
How to manage the interaction:
Taking Envas Injection 1 ml with aliskiren is not recommended, but it can be taken together if your doctor advises. However, contact your doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, or feelings of heaviness in the legs. Do not stop taking any medications without consulting a doctor.
Severe
How does the drug interact with Envas Injection 1 ml:
Using Envas Injection 1 ml together with Irbesartan may increase the risk of side effects such as low blood pressure, kidney function impairment, and a condition called hyperkalemia (high blood potassium).
How to manage the interaction:
Although taking Irbesartan with Envas Injection 1 ml together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult a doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, and feelings of heaviness in your legs. Do not stop using any medications without talking to a doctor.
Using Envas Injection 1 ml together with Irbesartan may increase the risk of side effects such as low blood pressure, kidney function impairment, and a condition called hyperkalemia (high blood potassium).
How to manage the interaction:
Although taking Irbesartan with Envas Injection 1 ml together can result in an interaction, it can be taken if a doctor has prescribed it. However, consult a doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, and feelings of heaviness in your legs. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Envas Injection 1 ml:
Envas Injection 1 ml, when taken together with Tizanidine, may lead to hypotension (low blood pressure) due to the additive effect.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Tizanidine may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hypotension, such as headache, dizziness, drowsiness, fainting, or irregular heartbeat. It is advised not to drive or operate any machinery that requires alertness and to be cautious when getting up from a sitting or lying position. Do not discontinue any medication without consulting your doctor.
Envas Injection 1 ml, when taken together with Tizanidine, may lead to hypotension (low blood pressure) due to the additive effect.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Tizanidine may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hypotension, such as headache, dizziness, drowsiness, fainting, or irregular heartbeat. It is advised not to drive or operate any machinery that requires alertness and to be cautious when getting up from a sitting or lying position. Do not discontinue any medication without consulting your doctor.
EnalaprilPotassium citrate
Severe
How does the drug interact with Envas Injection 1 ml:
Taking Envas Injection 1 ml with Potassium citrate increases the potassium levels in the blood, which may lead to hyperkalemia. In severe cases, hyperkalemia may lead to muscular paralysis, kidney damage, and cardiac problems. The risk is increased if you are elderly, dehydrated, or have a history of kidney or heart disease.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Potassium citrate may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Taking Envas Injection 1 ml with Potassium citrate increases the potassium levels in the blood, which may lead to hyperkalemia. In severe cases, hyperkalemia may lead to muscular paralysis, kidney damage, and cardiac problems. The risk is increased if you are elderly, dehydrated, or have a history of kidney or heart disease.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Potassium citrate may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
EnalaprilPotassium iodide
Severe
How does the drug interact with Envas Injection 1 ml:
Taking Envas Injection 1 ml with Potassium iodide increases the potassium levels in the blood, which may lead to hyperkalemia. In severe cases, hyperkalemia may lead to muscular paralysis, kidney damage, and cardiac problems. The risk is increased if you are elderly, dehydrated, or have a history of kidney or heart disease.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Potassium iodide may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, coconut and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Taking Envas Injection 1 ml with Potassium iodide increases the potassium levels in the blood, which may lead to hyperkalemia. In severe cases, hyperkalemia may lead to muscular paralysis, kidney damage, and cardiac problems. The risk is increased if you are elderly, dehydrated, or have a history of kidney or heart disease.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Potassium iodide may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, coconut and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Envas Injection 1 ml:
Envas Injection 1 ml combined with Trimethoprim can cause hyperkalemia by elevating blood potassium levels. In severe cases, hyperkalemia can induce muscle paralysis, renal damage, and cardiac problems. The risk is increased if you are elderly, dehydrated, or have a history of renal or cardiovascular disease.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Trimethoprim may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Envas Injection 1 ml combined with Trimethoprim can cause hyperkalemia by elevating blood potassium levels. In severe cases, hyperkalemia can induce muscle paralysis, renal damage, and cardiac problems. The risk is increased if you are elderly, dehydrated, or have a history of renal or cardiovascular disease.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Trimethoprim may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Envas Injection 1 ml:
Teriflunomide can cause liver damage, and taking it with medications like Envas Injection 1 ml, which have a similar effect, increases the risk.
How to manage the interaction:
Although taking Envas Injection 1 ml and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. However, contact your doctor if you experience fever, chills, joint discomfort, swelling, skin irritation, itching, tiredness, stomach ache, dark urine, or bleeding. Do not stop using any medications without a doctor's advice.
Teriflunomide can cause liver damage, and taking it with medications like Envas Injection 1 ml, which have a similar effect, increases the risk.
How to manage the interaction:
Although taking Envas Injection 1 ml and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. However, contact your doctor if you experience fever, chills, joint discomfort, swelling, skin irritation, itching, tiredness, stomach ache, dark urine, or bleeding. Do not stop using any medications without a doctor's advice.
How does the drug interact with Envas Injection 1 ml:
Coadministration of Olmesartan medoxomil with Envas Injection 1 ml can elevate the risk of adverse effects such as low blood pressure, kidney impairment, and hyperkalemia (high blood potassium). Hyperkalemia can cause kidney failure, strong paralysis, abnormal heart rhythm, and cardiac arrest in extreme instances. If you are elderly, dehydrated, or have renal disease, diabetes, or severe heart failure, you are more prone to develop hyperkalemia while taking these medications.
How to manage the interaction:
Although taking olmesartan medoxomil together with Envas Injection 1 ml may result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of Olmesartan medoxomil with Envas Injection 1 ml can elevate the risk of adverse effects such as low blood pressure, kidney impairment, and hyperkalemia (high blood potassium). Hyperkalemia can cause kidney failure, strong paralysis, abnormal heart rhythm, and cardiac arrest in extreme instances. If you are elderly, dehydrated, or have renal disease, diabetes, or severe heart failure, you are more prone to develop hyperkalemia while taking these medications.
How to manage the interaction:
Although taking olmesartan medoxomil together with Envas Injection 1 ml may result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Envas Injection 1 ml:
Envas Injection 1 ml has the potential to cause liver damage; this effect can be increased by the coadministration of medications that affect the liver, such as Leflunomide. This effect can be seen even long after discontinuing leflunomide as it stays in your blood longer.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Leflunomide may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of liver damage like fever, chills, unusual bleeding, dark-coloured urine, light colour stools, yellowish discolouration of skin and eyes, and abdominal pain. It is advised not to consume alcohol while using these medications as it may increase the damage o the liver. Do not discontinue any medications without consulting your doctor.
Envas Injection 1 ml has the potential to cause liver damage; this effect can be increased by the coadministration of medications that affect the liver, such as Leflunomide. This effect can be seen even long after discontinuing leflunomide as it stays in your blood longer.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Leflunomide may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of liver damage like fever, chills, unusual bleeding, dark-coloured urine, light colour stools, yellowish discolouration of skin and eyes, and abdominal pain. It is advised not to consume alcohol while using these medications as it may increase the damage o the liver. Do not discontinue any medications without consulting your doctor.
Severe
How does the drug interact with Envas Injection 1 ml:
Coadministration of Envas Injection 1 ml with Telmisartan may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Telmisartan may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of Envas Injection 1 ml with Telmisartan may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Envas Injection 1 ml together with Telmisartan may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Drug-Food Interactions
ENALAPRILAT-1.25MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
ENALAPRILAT-1.25MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Consuming a high-potassium diet while taking Envas Injection 1 ml can cause hyperkalemia (elevated blood potassium levels). Hyperkalemia may lead to dizziness, lightheadedness, fainting, or a rapid heartbeat. Avoid the consumption of potassium-rich foods.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Consuming a high-potassium diet while taking Envas Injection 1 ml can cause hyperkalemia (elevated blood potassium levels). Hyperkalemia may lead to dizziness, lightheadedness, fainting, or a rapid heartbeat. Avoid the consumption of potassium-rich foods.
Alcohol
Unsafe
Do not consume alcohol while on treatment with Envas Injection 1 ml as it may worsen the side effects like dizziness and also may increase blood pressure.
Pregnancy
Unsafe
The use of Envas Injection 1 ml is contraindicated during the second and third trimester of pregnancy. It may cause harm to the developing fetus. Inform your doctor if you are pregnant before receiving Envas Injection 1 ml.
Breast Feeding
Unsafe
Envas Injection 1 ml may be excreted in human milk. Therefore, it is not recommended for breastfeeding mothers as it may be unsafe for the baby. Inform your doctor if you are breastfeeding before receiving Envas Injection 1 ml. Your doctor will decide whether you stop breastfeeding or discontinue the use of Envas Injection 1 ml based on the benefits and risks.
Driving
Caution
Envas Injection 1 ml may cause dizziness. Hence, do not drive or operate machines after receiving this medicine.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Envas Injection 1 ml. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Elderly patients with liver impairment should start the treatment with a lower dose.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Envas Injection 1 ml. Envas Injection 1 ml may cause renal failure in some patients. Hence, inform your doctor if the patient develops any symptoms. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Elderly patients with renal impairment should start the treatment with a lower dose.
Children
Unsafe
Envas Injection 1 ml is not recommended for use in children as the safety and efficacy are not established for this age group.
Heart
Envas Injection 1 ml should be avoided in individuals with heart problems unless specifically advised by a doctor, as it may lead to complications like low blood pressure or kidney issues. Always seek medical guidance before use.
Geriatrics
Caution
Envas Injection 1 ml should be used cautiously in geriatric patients, as age-related kidney or cardiovascular changes may increase the risk of side effects like low blood pressure or impaired kidney function. Always consult your doctor to determine if it's appropriate for your condition.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
